Skip to main content

Table 6 Comparison of PFS and OS between two groups (\(\overline{x} \pm s\))

From: Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients

Groups

OSR (%)

PFS (month)

OS (month)

The control group (n = 78)

65 (83.33)

8.82 ± 2.65

14.26 ± 2.79

The observation group (n = 80)

72 (90.00)

10.98 ± 2.52

18.56 ± 3.25

t value

1.523

5.251

8.914

P value

0.217

< 0.001

< 0.001